Life Science Big News Roundup: Lexaria Receives Cannabis R&D License; Harvest One Phase II Clinical Trials on Satipharm CBD GelPell® Published in Peer-Reviewed Medical Journal Life Science Investing
Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors Cannabis Investing News
Innovate Biopharmaceuticals Doses First Patient in Phase 3 Clinical Trial CeD LA3001 Biotech Investing
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 Biotech Investing
